J Clin Sleep Med. 2021 Oct 20; doi: 10.5664/jcsm.9724. Epub 2021 Oct 20.
Past year use or misuse of an opioid is associated with use of a sedative-hypnotic medication: a NSDUH study.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Andrew S Tubbs, Sadia B Ghani, Michelle Naps, Michael A Grandner, Michael D Stein, Subhajit Chakravorty
Affiliations
Affiliations
- Sleep and Health Research Program, Department of Psychiatry, University of Arizona College of Medicine - Tucson, Tucson, AZ.
- School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA.
- Department of Health Law, Policy and Management, Boston University School of Public Health, Boston MA.
- Behavioral Medicine and Addictions Research Unit, Butler Hospital, Providence RI.
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
- Departments of Psychiatry and R&D, Cpl. Michael J. Crescenz VA Medical Center, Philadelphia, PA.
PMID: 34666879
DOI: 10.5664/jcsm.9724
Abstract
STUDY OBJECTIVES: Prescription use and misuse of opioids are linked to greater sleep disturbance. However, there are limited data on the prevalence of sedative-hypnotic medication use among persons who use opioids. Therefore, this study examined whether past year sedative-hypnotic use among persons who used/misused opioids was higher than among individuals who did not use opioids.
METHODS: Data were acquired from the U.S. National Survey on Drug Use and Health for 2015-2018. Use of a sedative benzodiazepine (temazepam, flurazepam, triazolam) or a Z-drug (eszopiclone, zaleplon, zolpidem) were examined in relation to use/misuse of an opioid within the past year. Logistic regression models estimated the associations between opioids and sedative-hypnotics using inverse probability of treatment weighting. A secondary machine learning analysis tested six binary classifiers to predict sedative-hypnotic use based on opioid use/misuse and other covariates.
RESULTS: Of 171,766 respondents, 24% used a prescription opioid while 3.6% misused an opioid in the past year. Among those who used a prescription opioid, 1.9% received a sedative benzodiazepine and 9% received a Z-drug during the same timeframe. Use of an opioid was associated with greater odds of sedative benzodiazepine use (OR: 4.4 [3.61, 5.4]) and Z-drug use (OR 3.8 [3.51, 4.09]), and stronger associations were noted for misuse of an opioid. Machine learning models accurately classified sedative-hypnotic medication use for over 70% of respondents based on opioid use/misuse.
CONCLUSIONS: Sedative-hypnotic use is common among persons who use opioids, which is concerning given the elevated mortality risk with concurrent use of these substances.
© 2021 American Academy of Sleep Medicine.
Keywords: analgesics; and sedatives; chronic pain; hypnotics; maintenance disorders; opioid; opioid-related disorders; sleep initiation
Publication Types